Sera Prognostics, Inc.
- SERA
- NASDAQ
- Medical devices
- Pregnancy Diagnostics (PreTRM)
- Women's Health Biomarkers
$2.06
Today +1.48%Quote Oct 16, 2026, 08:00 PM UTC
−0.48%over the last month
Max drawdown −6.1%From 1-month high −3.3%3 months −1.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$104.0M
Approximate share count
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$6.00
+191.3% from here
Floor
$2.02
2.2% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SERAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Medical devices
Employees
72